NOC vs TRVI · P/E 17, rev $20.76B vs $2.32B cap
Northrop Grumman Corporation (NOC) versus Trevi Therapeutics Inc (TRVI) — a side-by-side from cached financials, not a winner call.
Northrop Grumman Corporation (NOC) is a aerospace & defense company listed on NYSE.
Trevi Therapeutics Inc (TRVI) is a biotechnology company listed on NASDAQ.
Latest reported NOC revenue for 2026-06-30 was $20.76B. Net income was $1.97B. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
TRVI does not have a complete income-statement cache yet.
NOC currently screens at market cap $78.14B and trailing P/E 17.2. TRVI currently screens at market cap $2.32B.
Not investment advice. Open the NOC and TRVI stock pages for the full models.
Not investment advice.